ALLISON ANDREWS: Open Payments
NPI 1578857173 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,116 in 140 payments from 37 companies in 2025. Trend: 2023 $3,017 · 2024 $3,546 · 2025 $3,116
Food & beverage: $3,116
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $523 |
| Amgen Inc. | 9 | $240 |
| UCB, Inc. | 10 | $221 |
| Eisai Inc. | 4 | $158 |
| ARGENX US, INC. | 6 | $154 |
| Biogen, Inc. | 8 | $151 |
| TG Therapeutics, Inc. | 6 | $141 |
| Teva Pharmaceuticals USA, Inc. | 7 | $136 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Lundbeck LLC | 5 | $97 |
Products named: LEQEMBI, UPLIZNA, BOTOX, UBRELVY, ZEPOSIA, VYVGART HYTRULO, BRIUMVI, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
